Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10201824rdf:typepubmed:Citationlld:pubmed
pubmed-article:10201824lifeskim:mentionsumls-concept:C0013227lld:lifeskim
pubmed-article:10201824lifeskim:mentionsumls-concept:C0242640lld:lifeskim
pubmed-article:10201824lifeskim:mentionsumls-concept:C0752086lld:lifeskim
pubmed-article:10201824lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:10201824lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:10201824lifeskim:mentionsumls-concept:C0255738lld:lifeskim
pubmed-article:10201824pubmed:issue5lld:pubmed
pubmed-article:10201824pubmed:dateCreated1999-6-4lld:pubmed
pubmed-article:10201824pubmed:abstractTextWe synthesized the glucuronides of MS-209 to identify the two main unknown metabolites in human urine. Reaction of MS-209 and glucuronyl trichloroacetimidate gave two beta-isomers, which were each glucuronate of (R)- and (S)-MS-209. These spectrum data were identical with the metabolites.lld:pubmed
pubmed-article:10201824pubmed:languageenglld:pubmed
pubmed-article:10201824pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10201824pubmed:citationSubsetIMlld:pubmed
pubmed-article:10201824pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10201824pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10201824pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10201824pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10201824pubmed:statusMEDLINElld:pubmed
pubmed-article:10201824pubmed:monthMarlld:pubmed
pubmed-article:10201824pubmed:issn0960-894Xlld:pubmed
pubmed-article:10201824pubmed:authorpubmed-author:SuzukiTTlld:pubmed
pubmed-article:10201824pubmed:authorpubmed-author:MabuchiKKlld:pubmed
pubmed-article:10201824pubmed:authorpubmed-author:FukazawaNNlld:pubmed
pubmed-article:10201824pubmed:issnTypePrintlld:pubmed
pubmed-article:10201824pubmed:day8lld:pubmed
pubmed-article:10201824pubmed:volume9lld:pubmed
pubmed-article:10201824pubmed:ownerNLMlld:pubmed
pubmed-article:10201824pubmed:authorsCompleteYlld:pubmed
pubmed-article:10201824pubmed:pagination659-62lld:pubmed
pubmed-article:10201824pubmed:dateRevised2006-5-20lld:pubmed
pubmed-article:10201824pubmed:meshHeadingpubmed-meshheading:10201824...lld:pubmed
pubmed-article:10201824pubmed:meshHeadingpubmed-meshheading:10201824...lld:pubmed
pubmed-article:10201824pubmed:meshHeadingpubmed-meshheading:10201824...lld:pubmed
pubmed-article:10201824pubmed:meshHeadingpubmed-meshheading:10201824...lld:pubmed
pubmed-article:10201824pubmed:meshHeadingpubmed-meshheading:10201824...lld:pubmed
pubmed-article:10201824pubmed:meshHeadingpubmed-meshheading:10201824...lld:pubmed
pubmed-article:10201824pubmed:year1999lld:pubmed
pubmed-article:10201824pubmed:articleTitleSynthesis of glucuronides of multidrug resistance reversing drug MS-209.lld:pubmed
pubmed-article:10201824pubmed:affiliationLife Sciences Laboratory, Performance Materials R&D Center, Mitsui Chemicals, Inc., Mobara, Chiba, Japan.lld:pubmed
pubmed-article:10201824pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:10201824lld:chembl